The role of public education in the early detection of melanoma

Expert Review of Dermatology

Volumn 4, Issue 2, 2009, Pages 119-130

  Nikolau, Vasiliki ^a   del Marmol, Veronique ^b   Stratigos, Alexander J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Early detection; Educational aids; Internet; Melanoma; Prevention; Public education; Skin cancer; Skin self examination

Indexed keywords

ARTICLE; AWARENESS; CANCER DIAGNOSIS; CANCER SCREENING; CUTANEOUS MELANOMA; EARLY DIAGNOSIS; EDUCATIONAL TECHNOLOGY; HEALTH CARE SYSTEM; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; INFORMATION DISSEMINATION; MEDICAL INFORMATION SYSTEM; MELANOMA; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; SELF EXAMINATION; SOCIAL STATUS;

EID: 69949160109     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/edm.09.7     Document Type: Article

References (111)

1. Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HK. Melanoma incidence and mortality among US whites, 1969-1999. JAMA 288, 1719-1720 (2002).
2. IARC Cancerbase. Globocan 2000: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Press, Lyon, France (2001).
3. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int. J. Cancer 92, 457-462 (2001).
4. Ries LAG, Eisner MP, Kosary CL et al. SEER Cancer Statistics Review, 1975-2002. National Cancer Institute, NIH, Bethesda, MD, USA (2003).
5. De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int. J. Cancer 107, 119-126 (2003).
6. Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. Int. J. Epidemiol. 29, 416-423 (2000).
7. MacKie RM, Bray CA, Hole DJ et al. incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 360, 587-591 (2002).
8. Bosetti C, La Vecchia C, Naldi L, Lucchini F, Negri E, Levi F. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res. 14, 301-309 (2004).
9. Lindholm C, Andersson R, Dufmats M et al. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer 101, 2067-2078 (2004).
10. Demierre MF. Thin melanomas and regression, thick melanomas and older men: prognostic implications and perspectives on secondary prevention. Arch. Dermatol. 138, 678-682 (2002).
11. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northerm California and national trends 1990-2000. J. Invest. Dermatol. 125, 685-691 (2005).
12. Tucker MA, Goldstein AM. Melanoma etiology: where are we? Oncogene 22, 3042-3052 (2003).
13. Autier P, Boniol M, Doré JF. Sunscreen use and increased duration of intentional sun exposure: still a burning issue. Int. J. Cancer 121, 1-5 (2007).
14. Gallagher RP, Spinelli JJ, Lee TK. Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev. 14, 562-566 (2005).
15. Grant WB. Solar ultraviolet irradiance and cancer incidence and mortality. Adv. Exp. Med. Biol. 624, 16-30 (2008).
16. Halpern AC, Lieb JA. Early melanoma diagnosis: a success story that leaves room for improvement. Curr. Opin. Oncol. 19, 109-115 (2007).
17. Lasithiotakis KG, Leiter U, Gorkievicz R et al. The incidence and mortality of cutaneous melanoma in Southerm Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 107, 1331-1339 (2006).
18. Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front. Biosci. 11, 1244-1254 (2006).
19. Garbe C, McLeod GR, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89, 1269-1278 (2000).
20. Crocetti E, Carli P. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur. J. Dermatol. 13, 72-75 (2003).
21. Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL. Screening, early detection and trends for melanoma: current status (2000-2006) and future directions. J. Am. Acad. Dermatol. 57, 555-572 (2007).
22. Stratigos AJ, Katsambas AD. The value of screening in melanoma. Clin. Dermatol. 27, 10-25 (2009).
23. Koh HK, Norton LA, Geller AC et al. Evaluation of the American Academy of Derm atology's national skin cancer detection and screening program. J. Am. Acad. Dermatol. 34, 971-978 (1996).
24. Richard MA, Grob JJ, Avril MF et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch. Dermatol. 135, 269-274 (1999).
25. Melia J, Harland C, Moss S, Eiser JR, Pendry L. Feasibility of targeted early det- ection for melanoma: a population-based screening study. Br. J. Cancer 82, 1605-1609 (2000).
26. Jackson A, Wilkinson C, Pill R. Moles and melanomas - who's at risk, who knows, and who cares? A strategy to inform those at high risk. Br. J. Gen. Pract. 49, 199-203 (1999).
27. Oliveria SA, Christos PJ, Halpern AC, Fine JA, Barnhill RL, Berwick M. Patient knowledge, awareness and delay in seeking medical attention for malignant melanoma. J. Clin. Epidemiol. 52, 1111-1116 (1999).
28. Berwick M, Armstrong BK, Ben-Porat L et al. Sun exposure and mortality from melanoma. J. Natl Cancer Inst. 97, 195-199 (2005).
29. Baumert J, Plewg G, Volkenandt M, Schmid-Wendtner MH. Factors associated with a high tumour thickness in patients with melanoma. Br. J. Dermatol. 156, 938-944 (2007).
30. Harland CC, MadeleY RJ, Millard LG. Information leaflets in the dermatology out-patient waiting area. Br. J. Dermatol. 127, 492-496 (1992).
31. Rhodes AR. Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer 75(2 Suppl.), 613-636 (1995).
32. Elwood M, Aitken JF, English DR. Prevention and screening. In: Cutaneous Melanoma (Fourth Edition.). Balch CM, Houghton AN, Sober AJ, Soong S (Eds). Quality Medical Publishing, St Louis, MO, USA 93-120 (2003).
33. Marks R. Campaigning for melanoma prevention: a model for a health education program. J. Eur. Acad. Dermatol. Venereol. 18, 44-47 (2004).
34. Borland R, Marks R, Noy S. Public knowledge about characteristics of moles and melanomas. Aust. J. Publ. Health 16, 370-375 (1992).
35. Giles GG, Armstrong BK, Burton RC, Staples MP, Thurs?eld VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1031 and 1994. BMJ 312, 1121-1125 (1996).
36. Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB. Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J. Am. Acad. Dermatol. 54, 105-114 (2006).
37. Aitken JF, Youl PH, Janda M, Lowe JB, Ring IT, Elwood M. Increase in skin cancer screening during a community-based randomized intervention trial. Int. J. Cancer 118, 1010-1016 (2006).
38. Del Mar CB, Green AC, Battistutta D. Do public media campaigns designed to increase skin cancer awareness result in increased skin excision rates? Aust. NZ J. Public Health 21, 751-754 (1997).
39. Doherty VR, MacKie RM. Experience of a public education programme on early detection of cutaneous malignant melanoma. BMJ 297, 388-391 (1988).
40. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 304, 1012-1015 (1992).
41. MacKie RM, Bray C, Vestey J et al. Melanoma incidence and mortality in Scotland 1979-2003. Br. J. Cancer 96, 1772-1777 (2007).
42. Melia J. Early detection of cutaneous malignant melanoma in Britain. Int. J. Epidemiol. 24(Suppl. 1), S39-S44 (1995).
43. Graham-Brown RA, Osborne JE, London SP et al. The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br. J. Dermatol. 122, 53-59 (1990).
44. Whitehead SM, Wroughton MA, Elwood JM, Davison J, Stewart M. Effects of a health education campaign for the earlier diagnosis of melanoma. Br. J. Cancer 60, 421-425 (1989).
45. Herd RM, Cooper EJ, Hunter JA et al. Cutaneous malignant melanoma. Publicity, screening clinics and survival - the Edinburgh experience 1982-1990. Br. J. Dermatol. 132, 563-570 (1995).
46. Melia J, Cooper EJ, Frost T et al. Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br. J. Dermatol. 132, 414-421 (1995).
47. Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE et al. Trends in mortality from malignant melanoma in Sweden, 1970-1996. Cancer 89, 348-355 (2000).
48. Rossi CR, Vecchiato A, Bezze G et al. Early detection of melanoma: an educational campaign in Padova, Italy. Melanoma Res. 10, 181-187 (2000).
49. Cristofolini M, Bianchi R, Boi S et al. Effectiveness of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. J. Dermatol. Surg. Oncol. 19, 117-120 (1993).
50. Schneider JS, Moore DH, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J. Am. Acad. Dermatol. 58, 741-749 (2008).
51. Geller AC, Emmons K, Brooks DR et al. Skin cancer prevention and detection practices among siblings of patients with melanoma. J. Am. Acad. Dermatol. 49, 631-638 (2003).
52. Stratigos A, Nikolaou V, Kedicoglou S et al. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening day campaign in Greece. J. Eur. Acad. Dermatol. Venereol. 21, 56-62 (2007).
53. Bulliard JL, Maspoli M, Panizzon RG, Hohl D, Gueissaz F, Levi F. Evaluation of the Euromelanoma skin cancer screening campaign: the Swiss experience. J. Eur. Acad. Dermatol. Venereol. 22, 365-366 (2008).
54. McCarthy WH.The Australian experience in sun protection and screening for melanoma. J. Surg. Oncol. 86, 236-245 (2004).
55. Lowe JB, Ball J, Lynch BM et al. Acceptability and feasibility of a community-based screening programme for melanoma in Australia. Health Promot. Int. 19, 437-444 (2004).
56. Stryker JE, Solky BA, Emmons KM. A content analysis of News coverage of skin cancer prevention and detection, 1979 to 2003. Arch. Dermatol. 141, 491-496 (2005).
57. Weinstock MA. Cutaneous melanoma: public health approach to early detection. Deramtol. Ther. 19, 26-31 (2006).
58. Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician and self examination of the skin. CA Cancer J. Clin. 35, 131-151 (1985).
59. Weinstock M. ABCD, ABCDE, ABCCCDEEEEFNU. Arch. Dermatol. 142, 528 (2008).
60. Abbasi NR, Shaw HM, Rigel DS et al. Early diagnosis of cutaneous melanoma-revisiting the ABCD criteria. JAMA 292, 2771-2776 (2004).
61. Abbasi NR, Yancovitz M, Gutkowicz-Krusin D et al. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch. Dermatol. 144, 469-474 (2008).
62. Warycha M, Christos P, Mazumbar M et al. Changes in the presentation of nodular and superficial spreading melanoma over 35 years. Cancer 113, 3341-3348 (2008).
63. Thomas L, Tranchand P, Berard F, Secchi T, Colin C, Moulin G. Semiological value of the ABCDE criteria in the diagnosis of cutaneous pigmented tumours. Dermatology 197, 11-17 (1998).
64. Robinson JK, Turrisi R. Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma. Arch. Dermatol. 142, 447-452 (2006).
65. Branstrom R, Hedblad MA, Krakau I, Ullen H. Laypersons' perceptual, discrimination of pigmented skin lesions. J. Am. Acad. Dermatol. 46, 667-673 (2002).
66. Grob JJ. The ugly duckling sign: identification of the common characteristics of nevi in a individual as a basis for melanoma screening. Arch. Dermatol. 134, 103-104 (2007).
67. Mascaro JM Jr, Mascaro JM. The dermatologist's position concerning nevi: a vision ranging form the 'ugly duckling' to 'little red riding hood'. Arch. Dermatol. 134, 1484-1485 (2008).
68. Miles F, Meehan JW. Visual discrimination of pigmented skin lesions. Health Psychol. 14, 171-177 (1995).
69. Borland R, Mee V, Meehan JW. Effects of photographs and written descriptors on melanoma detection. Health Educ. Res. 12, 375-384 (1997).
70. Girardy S, Gaudy C, Gouvernet J, Teston J, Richard MA, Grob JJ. Superiority of a cognitive education with photographs over ABCD criteria in the education of the general popualtion to the early detection of melanoma: a randomized study. Int. J. Cancer 118, 2276-2280 (2006).
71. Geller AC, Koh HK, Miller DR, Clapp RW, Mercer MB, Lew RA. Use of health services before the diagnosis of melanoma: implications for early detection and screening. J. Gen. Intern. Med. 7, 154-157 (1992).
72. Grob JJ, Richard MA, Gouvernet J et al. The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: a prospective study. Int. J. Cancer 102, 34-38 (2002).
73. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is physician detection associated with thinner melanomas? JAMA 281, 640-643 (1999).
74. Carli P, DeGiorgi V, Palli D et al. Dermatologist detection and skin self examination are associated with thinner melanomas: results from a survey of the Italian multidisciplinary group on melanoma. Arch. Dermatol. 139, 607-612 (2003).
75. Krige JEJ, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA. Delay in the diagnosis of cutaneous malignant melanoma: a prospective study in 250 patients. Cancer 68, 2064-2068 (1991).
76. Elwood JM. Screening for melanoma and options for its evaluation. J. Med. Screening 1, 22-38 (1994).
77. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J. Natl Cancer Inst. 88, 17-23 (1996).
78. Weinstock MA, Risica PM, Martin RA et al. Melanoma early detection with thorough skin self examination. The "Check it out" randomized trial. Am. J. Prev. Med. 32, 517-524 (2007).
79. Wolff T, Tai E, Miller T. Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 150, 194-198 (2009).
80. Weinstock MA, Martin RA, Risica PM et al. Thorough skin examination for the early detection of melanoma. Am. J. Prev. Med. 17, 169-175 (1999).
81. Robinson JK, Rigel DS, Amonette RA. What promotes skin self-examination? J. Am. Acad. Dermatol. 39, 752-757 (1998).
82. Miller DR, Geller AC, Wyatt SW et al. Melanoma awareness and self examination practices: results of a United States survey. J. Am. Acad. Deramtol. 34, 962-970 (1996).
83. Chiu V, Won E, Malik M, Weinstock MA. The use of mole-mapping diagrams to increase skin self-examination accuracy. J. Am. Acad. Dermatol. 55, 245-250 (2005).
84. Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC. Patient adherence to skin self-examination. Effect of nurse intervention with photographs. Am. J. Prev. Med. 26, 152-155 (2004).
85. Lee KB, Weinstock MA, Risica PM. Components of a successful intervention for monthly skin-examination for early detection of melanoma: The "Check It Out" trial. J. Am. Acad. Dermatol. 58, 1006-1012 (2008).
86. Robinson JK, Turrisi R, Stapleton J. Ef?cacy of a partner assistance intervention designed to increase skin self examination performance. Arch. Dermatol. 143, 37-41 (2007).
87. Geller AC, Emmons KM, Brooks DR et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer 107, 806-814 (2006).
88. Hanrahan PF, Hersey P, D'Este CA. Factors involved in presentation of older people with thick melanoma. Med. J. Aust. 169, 410-414 (1998).
89. Hersey P, Sillar RW, Howe CG et al. Factors related to the presentation of patients with thick primary melanomas. Med. J. Aust. 154, 583-587 (1991).
90. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch. Dermatol. 138, 609-614 (2002).
91. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J. Natl Cancer Inst. 93, 678-683 (2001).
92. De Vries E, Coebergh JW. Melanoma incidence has risen in Europe. BMJ 331, 698 (2005).
93. Geller AC, Sober AJ, Zhang Z et al. Strategies for improving melanoma education and screening for men age >or=50 years: findings from the American Academy of Dermatological National Skin Cancer Sreening Program. Cancer 95, 1554-1561 (2002).
94. Janda M, Youl PH, Lowe JB et al. What motivates men age > or =50 years to participate in a screening program for melanoma? Cancer 107, 815-823 (2006).
95. Del Marmol V, de Vries E, Roseeuw D et al. A prime minister managed to attract elderly men in a Belgian Euromelanoma campaign. Eur. J. Cancer (2009) (Epub ahead of print).
96. Geller J, Swetter SM, Leyson J, Miller DR, Brooks K, Geller AC. Crafting a melanoma educational campaign to reach middle-aged and older men. J. Cutan. Med. Surg. 10, 259-268 (2006).
97. Montella M, Crispo A, Grimaldi M et al. An assessment of factors related to tumor thickness and delay in diagnosis of melanoma in southern Italy. Prev. Med. 35, 271-277 (2002).
98. Richard MA, Grob JJ, Avril MF et al. Delays in diagnosis and melanoma prognosis (I): the role of patients. Int. J. Cancer 89, 271-279 (2000).
99. Roetzheim RG, Pal N, Tennant C et al. Effects of health insurance and race on early detection of cancer. J. Natl Cancer Inst. 91, 1409-1415 (1999).
100. Chen X, Siu L. Impact of the media and the internet on oncology: survey of cancer patients and oncologists in Canada. J. Clin. Oncol. 19, 4291-4297 (2001).
101. Larkin M. Online support groups gaining credibility. Lancet 355, 1834 (2000).
102. Fox S, Rainie L. The Online Health Care Revolution: How the Web Helps Americans Take Better Care of Themselves. Pen Charitable Trusts, Washington, DC, USA (2000).
103. Bichakjian CK, Schwartz JL, Wang TS et al. Melanoma information on the internet: often incomplete - a public health opportunity? J. Clin. Oncol. 20, 134-141 (2002).
104. Diaz JA, Griffith RA, NG JJ et al. Patients' use of the internet for medical information. J. Gen. Intern. Med. 17, 180-185 (2002).
105. Biermann JS, Golladay GJ, Greenfield MLVH, Baker LH. Evaluation of cancer information on the internet. Cancer 86, 381-390 (2000).
106. McClung HJ, Murray HD, Heitlinger LA. The internet as a source for current patient information. Pediatrics 101, 1-4 (1998).
107. Griffiths KM, Christensen H. Quality of web based information on treatment of depression: cross sectional survey. BMJ 321, 1511-1515 (2000).
108. Sabel MS, Strecher VJ, Schwartz JL et al. Patterns of internet use and impact on patients with melanoma. J. Am. Acad. Dermatol. 52, 779-785 (2005).
109. Raghunathan R, Pham MT. All negative moods are not equal: motivational in?uences of anxiety and sadness on decision making. Organ. Behav. Hum. Decis. Process. 79, 56-77 (1999).
110. Helft PR, Hlubocky F, Daugherty CK. American oncologists' views on internet use by cancer patients: a mail survey of American Society of Clinical Oncology members. J. Clin. Oncol. 21, 942-947 (2003).
111. Ferguson T. Digital doctoring-opportunities and challenges in electronic patient-physician communication. JAMA 280, 1361-1362 (1998).